<?xml version="1.0" encoding="UTF-8"?>
<p>In March, legislatures in Canada, Chile, and Ecuador laid the legal groundwork for the issuance of compulsory licenses to address COVID-19. Canada’s COVID-19 Emergency Response Act amended the Canadian Patent Act to allow for a speedier process for issuing a compulsory license on public health grounds. The amendment allows the government to issue a license for necessary innovations and to negotiate remuneration later [
 <xref rid="R12" ref-type="bibr">12</xref>]. Chile’s Chamber of Deputies (the lower house of its Congress) has passed a resolution granting the use of compulsory licenses for the prevention and treatment of COVID-19. Specifically, the resolution declares that the coronavirus pandemic constitutes sufficient justification to grant compulsory licenses for COVID-19-related technologies [
 <xref rid="R13" ref-type="bibr">13</xref>]. Similarly, a Committee of the National Assembly in Ecuador has passed a resolution requiring the Ecuadorian President and Minister of Health to provide free or affordable access to COVID-19-related preventative, diagnostic, and treatment technologies through the use of compulsory licenses [
 <xref rid="R14" ref-type="bibr">14</xref>]. Other developing countries should take similar legal and legislative steps to establish a framework for using compulsory licenses in case it is necessary.
</p>
